Endymed Financial Statements From 2010 to 2024

ENDY Stock   302.00  11.90  4.10%   
Endymed financial statements provide useful quarterly and yearly information to potential Endymed investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Endymed financial statements helps investors assess Endymed's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Endymed's valuation are summarized below:
Endymed does not presently have any fundamental signals for analysis.
Check Endymed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Endymed's main balance sheet or income statement drivers, such as , as well as many indicators such as . Endymed financial statements analysis is a perfect complement when working with Endymed Valuation or Volatility modules.
  
This module can also supplement various Endymed Technical models . Check out the analysis of Endymed Correlation against competitors.

Endymed Company Operating Margin Analysis

Endymed's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Endymed Operating Margin

    
  0.06 %  
Most of Endymed's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Endymed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Endymed has an Operating Margin of 0.0556%. This is 100.16% lower than that of the Health Care Equipment & Supplies sector and 100.14% lower than that of the Health Care industry. The operating margin for all Israel stocks is 101.01% lower than that of the firm.

Endymed Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Endymed's current stock value. Our valuation model uses many indicators to compare Endymed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Endymed competition to find correlations between indicators driving Endymed's intrinsic value. More Info.
Endymed is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about  0.18  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Endymed is roughly  5.57 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Endymed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Endymed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Endymed Financial Statements

Endymed stakeholders use historical fundamental indicators, such as Endymed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Endymed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Endymed's assets and liabilities are reflected in the revenues and expenses on Endymed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Endymed. Please read more on our technical analysis and fundamental analysis pages.
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Endymed Stock

Endymed financial ratios help investors to determine whether Endymed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endymed with respect to the benefits of owning Endymed security.